msh (11-13) has been researched along with Colitis Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, MK; Kang, Y; Merlin, D; Viennois, E; Xiao, B; Xu, Z; Zhang, M; Zhang, Y; Zhang, Z | 1 |
1 other study(ies) available for msh (11-13) and Colitis Gravis
Article | Year |
---|---|
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Compounding; Epithelial Cells; Gene Expression; Glucuronic Acid; Hexuronic Acids; Humans; Hyaluronic Acid; Hydrogels; Macrophages; Male; Melanocyte-Stimulating Hormones; Mice; Molecular Targeted Therapy; Nanoparticles; Particle Size; Peptide Fragments; RAW 264.7 Cells; Sodium Dodecyl Sulfate; Static Electricity; Tumor Necrosis Factor-alpha | 2017 |